NOVABAY PHARMACEUTICALS INC - COM (NBY)

CUSIP: 66987P102

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
3,066,355
Share change
-1,448,670
Total reported value
$1,902,960
Price per share
$0.62
Number of holders
19
Value change
-$909,973
Number of buys
6
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 66987P102?
CUSIP 66987P102 identifies NBY - NOVABAY PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVABAY PHARMACEUTICALS INC - COM (NBY) as of Q2 2015

As of 30 Jun 2015, NOVABAY PHARMACEUTICALS INC - COM (NBY) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,066,355 shares. The largest 10 holders included VANGUARD GROUP INC, GLENMEDE TRUST CO NA, WEDBUSH SECURITIES INC, Polar Securities Inc., RENAISSANCE TECHNOLOGIES LLC, Orbitronix, LP, GEODE CAPITAL MANAGEMENT, LLC, GARRISON BRADFORD & ASSOCIATES INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and DEUTSCHE BANK AG\. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.